<DOC>
	<DOCNO>NCT00529815</DOCNO>
	<brief_summary>The purpose pilot study determine Real-Time Continuous Glucose Monitoring System ( CGMS ) effective method improve glycemic control patient type 2 diabetes episodic self blood glucose monitoring ( SBGM ) short- long-term . CGMS , include sensor self- insert skin discrete monitor record display blood sugar level nearly continuously , allow real time blood glucose monitoring . This prospective , randomize control trial compare participant type II diabetes use CGMS versus SBGM . The primary endpoint improvement glycemic control measure glycosylated hemoglobin ( A1C ) . The secondary endpoint compare mean daily glucose level , number hypoglycemic hyperglycemic event , amount time spend target blood glucose , perceive level diabetes-related stress two group . Participants randomize either control ( SBGM ) intervention ( CGMS ) group . Subjects intervention group alternate use CGMS episodic self blood glucose monitor four cycle two week 12 week study . The control group perform episodic SBGM throughout study . The intensified monitoring schedule group end end week 12 , glycemic control measurement A1C continue 52 week . A1C level draw 0 , 12 , 24 , 38 , 52 week . Mean daily blood glucose level , number hypo hyperglycemic event , duration time spend target blood glucose range download patient ' meter periodically throughout study . The SF-8 , general quality life questionnaire people chronic disease , Problem Areas Diabetes ( PAID ) , diabetes-related quality life questionnaire , complete begin end study . The result study may help highlight blood glucose monitoring method likely improve patient ' ability achieve maintain target level glycemic control .</brief_summary>
	<brief_title>Continuous Glucose Monitoring Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Age 18 old . 2 . Known Type 2 diabetes least 3 month 3 . Diet control , oral therapy , basal insulin ( e.g . glargine ) , oral therapy basal insulin 4 . A1C level 7 % 12 % . 5 . Able independently measure read finger stick blood glucose level Accuchek Aviva glucometer DexCom Continuous Glucose Monitoring device ( DexCom DTS7 ) . 6 . Subjects attend American Diabetes Association recognize Diabetes SelfManagement Education ( DSME ) program one WRHCS military treatment facility ( MTFs ) within past five year . 7 . Willing avoid minimize use acetaminophen ( Tylenol ) acetaminophen contain product overthecounter ( OTC ) medication study period ( Appendix 5 ) .. 1 . Female subject pregnant , lactating , plan become pregnant , without safe contraceptive method . 2 . A1C level less 7 great 12 . 3 . Subjects take glucocorticoid , amphetamine , anabolic , weightreducing agent course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Continuous</keyword>
	<keyword>blood</keyword>
	<keyword>glucose</keyword>
	<keyword>monitoring</keyword>
	<keyword>diabetes</keyword>
	<keyword>type2</keyword>
</DOC>